We are live on
!
Find out more
FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
1-Year Est. Return
44.84%
This Fund
S&P 500
This Quarter
Est. Return
-48.93%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
–
AUM
$133M
AUM Growth
-$130M
(-49%)
Cap. Flow
-$1.73M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EPZM
Epizyme, Inc
EPZM
|
+$1.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
AG
SAM
AC
QI
TAAM
NAM
MSKCC
BRC
Foresite Capital Management II's Q1 2022 Portfolio in Review
As of Q1 2022, Foresite Capital Management II held 2 positions worth $133M, down 49% from $263M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Foresite Capital Management II's Q1 2022 filing shows 1 closed position. The largest sale was Epizyme, Inc, an estimated $1.73M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Foresite Capital Management II fully exited Epizyme, Inc in Q1 2022, selling an estimated $1.73M.
- Foresite Capital Management II's ten largest holdings make up 100% of its $133M portfolio in Q1 2022.
- Foresite Capital Management II opened 0 new positions and closed 1 in Q1 2022.
- Foresite Capital Management II's portfolio value fell 49% quarter-over-quarter to $133M.
Based on Foresite Capital Management II's 13F filing for Q1 2022, filed 13 May 2022.